FindTrial
Sign In

EVALUATION OF SIDDHA MEDICINE VELLAI ERUKKAN SAMULA PARPAM FOR SWASAKASAM (ASTHMA)

PHASE II NON-RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA MEDICINE VELLAI ERUKKAN SAMULA PARPAM IN SWASAKASAM (ASTHMA) - Swasakasam

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028418
Enrollment
40
Registered
2020-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40-J47- Chronic lower respiratory diseases

Interventions

Intervention1: Phase II no randomized open clinical evaluation of Siddha Medicine Vellai Erukkan Samula Parpam in Swasakasam Asthma: Vellai Erukkan Samula Parpam Intervention2: Vellai ERUKKAN Samula P

Sponsors

Government Siddha Medical College Chennai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cough with tenacious sputum Dyspnea H/O Wheeze or without wheeze Chest tightness Dry cough

Exclusion criteria

Exclusion criteria: H/O Chronic bronchitis H/O Bronchiectasis H/O Bronchogenic carcinoma H/O Pulmonary TB H/O Congestive cardiac failure Pregnancy and lactating mothers Status asthmatics Will be excluded clinically or based on available medical reports

Design outcomes

Primary

MeasureTime frame
Outcome is mainly assessed by reduction in clinical symptoms and by comparing the peak expiratory flow rate 60% before and after treatmentTimepoint: 14 DAYS—

Secondary

MeasureTime frame
Outcome is mainly assessed by reduction in clinical symptoms and by comparing the peak expiratory flow rate 60% before and after treatmentTimepoint: 6WEEKS—

Countries

India

Contacts

Public ContactDr N Anbu

Government Siddha Medical College Chennai

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026